A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Brexpiprazole Impurity 36 - Request Quote

Picture of Brexpiprazole Impurity 36

Brexpiprazole Impurity 36

SZ CAT No:SZ-B011039
CAS No
NA
Mol.F.
C13H14BrNO2
Mol.Wt.
296.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Brexpiprazole Impurity 36 is chemically 1-(4-Bromobutyl)-7-hydroxyquinolin-2(1H)-one. Brexpiprazole Impurity 36 is supplied with detailed characterization data compliant with regulatory guideline. Brexpiprazole Impurity 36 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brexpiprazole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Brexpiprazole Impurity 36

Purchase Brexpiprazole Impurity 36

Brexpiprazole Impurity 36 suppliers

Brexpiprazole Impurity 36 manufacturers

Brexpiprazole Impurity 36 price

Order Brexpiprazole Impurity 36

Enquire Brexpiprazole Impurity 36

Brexpiprazole Impurity 36 cost

Brexpiprazole Impurity 36 Supplier

Brexpiprazole Impurity 36 Distributor

Brexpiprazole Impurity 36 for Method Validation

Brexpiprazole Reference Standard

Brexpiprazole Impurity 36 for ANDA Filing

Brexpiprazole Impurity 36 for Forced Degradation Studies

Brexpiprazole Impurity 36 Identification Standards

Brexpiprazole Impurity 36 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,